4CANHOTO LIMITED
Opportunity 73/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2024-12-31 | 2023-12-31 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 persons-with-significant-control
- • 1 confirmation-statement
Corporate timeline (17 events)Click to expand
- 2026-01-02📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-04-15📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-12-11📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2024-05-19📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-12-18📄change-person-director-company-with-change-dateofficers · CH01
- 2023-07-25📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-02-27📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-12-16📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2021-12-16📄change-person-director-company-with-change-dateofficers · CH01
- 2021-05-17📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-05-08📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-07-10📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-07-03📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-08-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2016-09-29📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2011-12-08🏢Company incorporatedAs 4CANHOTO LIMITED
- 2011-12-08➕MENEZES, Rajiv Basil, Dr appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +No director turnover: Company is 14 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 14 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Rajiv Basil Menezes Individual · British · DOB 01/1975 · age 51 | 50–75% | — | 50-75% shares | 06/04/2016 |
Michelle Prabhu Mascarenhas Individual · British · DOB 12/1977 · age 49 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 01/12/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · WA postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 121HT LTD→ 16310335 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| 189 LTD→ 16064606 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| 21D BIOENGINEERING LIMITED→ 09476569 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| 21D CLINICAL LIMITED→ 09476584 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| 23D GROUP LIMITED→ 17128365 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| 2B WELL CONSULTING LTD→ 15289841 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| 4 SEASONS MEDICAL CENTRE LTD→ 03679849 · est 1998 · no financials extracted | — | — | — | — | 27y | — | — |
| 964 DENT LTD→ 13668310 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| A3S MEDICARE LTD→ 10645414 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| A4S SOLUTIONS LIMITED→ 09788983 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| AA DENTISTRY LTD→ 14017700 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| AADHYA ENTERPRISES LIMITED→ 09723810 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.